| Clinical Research Projects |
 |
Cancer |
For more information regarding these studies, please contact Tracy Ackley at #795-7549 or 795-2935.
CENTRAL MAINE MEDICAL CENTER
COMPREHENSIVE CANCER PROGRAM
ONCOLOGY CLINICAL TRIALS
October 2008
BREAST
CALGB 40101
Cyclophosphamide and Doxorubicin (CA) (4 vs. 6 cycles) versus Paclitaxel (4 vs 6 cycles) as Adjuvant Therapy for Women with Node-Negative Breast Cancer: A 2x2 Factorial Phase III Randomized Study.
SWOG S0226
Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women with Metastatic Breast Cancer
IBCSG 25-02 ENROLLMENT SUSPENDED
A Phase III Trial of Evaluating the Role of Exemestane Plus GnRH Analogue as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer
NSABP B-39/RTOG 0413
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
NSABP B-42
A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer
PACCT-1
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial
BLADDER
CANCER CONTROL
GASTROINTESTINAL
CALGB 80101
Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
CALGB 80405 ENROLLMENT SUSPENDED
A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
RTOG 0822
A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination With Capecitabine and Oxaloplatin for Patients With Locally Advanced Rectal Cancer
GYN
LEUKEMIA
CALGB 9665
The CALGB Leukemia Tissue Bank--(Laboratory Companion Study)
CALGB 8461
Cytogenetic Studies in Acute Leukemia--(Laboratory Companion Study)
CALGB 10105
A Phase II Study of an Oral VEGF Receptor Tyrosine Kinase Inhibitor (PTK787/ZK 222584) (IND# 66370, NSC# 719335) in Myelodysplastic Syndrome (MDS)
LYMPHOMA
MELANOMA
PROSTATE
CALGB 90202
A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate Cancer Metastatic to Bone
RTOG 0534
A Phase III Trial of Short Term Androgen Deprivation With pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
RESPIRATORY
SWOG 0424
Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
ECOG 1505
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4 cm) – IIIA Non-Small Cell Lung Cancer (NSCLC)
RTOG 0617
A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy0 Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer
SYMPTOM CONTROL
|
